HARMONY BIOSCIENCES TO REPORT FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS ON FEBRUARY 22, 2024
PLYMOUTH MEETING, Pa., Feb. 8, 2024 /PRNewswire/ — Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY) today announced that it will report fourth quarter and full year 2023 financial results on Thursday, February 22, 2024, before the open of the U.S. financial markets. Harmony will host a conference call and live webcast on February 22, 2024, at 8:30 a.m. ET to discuss the results.
Related news for (HRMY)
- harmony biosciences holdings, inc. announces pricing of public offering of common stock by selling shareholders
- harmony biosciences holdings, inc. announces commencement of proposed public offering of common stock by selling shareholders
- HARMONY BIOSCIENCES PRELIMINARY UNAUDITED FOURTH QUARTER AND FULL YEAR 2023 NET PRODUCT REVENUE INCREASES MORE THAN 30 PERCENT; PROVIDES 2024 NET PRODUCT REVENUE GUIDANCE
- HARMONY BIOSCIENCES TO PRESENT AT THE 42ND ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE